Precision Optics (POCI) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
24 May, 2026Strategic focus and business model
Vertically integrated optics company leveraging proprietary micro-optics and imaging technologies for healthcare and defense/aerospace sectors, offering services from concept to mass manufacture.
Engages early with key medical device and defense clients, providing expertise in micro-optics, 3D, and digital imaging.
Maintains a robust pipeline for future commercial production, supported by ongoing R&D and intellectual property updates.
Differentiated by micro-optics, 3D imaging, and digital imaging capabilities, with over 25 years of technical experience.
Product and technology highlights
Offers millimeter-sized cameras and imaging systems enabling new and minimally invasive surgical procedures.
Designs and manufactures 3D endoscopes for robotic and minimally invasive surgery, with applications in 4K, fluorescence, and AR/VR systems.
Develops digital imaging electronics, including CMOS-based systems and LED illumination, supporting both single-use and reusable devices.
Unity Platform accelerates endoscopic device development, reducing costs and time to market through modular, customizable systems.
Key markets and recent orders
Serves medical device markets such as neurosurgery, ophthalmology, urology, and robotic surgery, with single-use endoscopes growing at 15–20% CAGR.
Expanding presence in defense/aerospace, focusing on satellite communications, UAVs, directed energy weapons, and laser communications.
Secured a $9 million single-use cystoscopy order (May 2024) and a top-tier aerospace program with $4 million annual commitments through 2026.
Latest events from Precision Optics
- Accelerated revenue growth driven by new production programs and robust technology pipeline.POCI
Lytham Partners Spring 2026 Investor Conference28 May 2026 - Record Q3 revenue, margin gains, and a $10M+ offering drove raised FY2026 guidance.POCI
Q3 202614 May 2026 - Strong revenue growth and major orders fuel expansion in medical and defense optics.POCI
Investor presentation16 Apr 2026 - Record revenue growth offset by margin compression and liquidity risks.POCI
Q2 202617 Feb 2026 - Shareholders will vote on director elections, executive pay, and auditor ratification at the 2025 meeting.POCI
Proxy Filing3 Feb 2026 - Votes will be cast on director elections, executive pay, and auditor ratification at the 2026 meeting.POCI
Proxy Filing2 Feb 2026 - Annual meeting to elect directors, approve executive pay, and ratify auditor, with strong governance.POCI
Proxy Filing2 Feb 2026 - Record engineering revenue and new orders support double-digit growth expectations for FY2025.POCI
Q4 202420 Jan 2026 - Strong product pipeline and new production ramp-ups set the stage for record growth in 2025.POCI
Lytham Partners Fall 2024 Investor Conference19 Jan 2026